Summary: Rauwolfia serpentina is a medicinal plant whose root contains reserpine, an old prescription blood pressure drug. Small trials show reserpine lowers systolic blood pressure, but it can cause serious side effects, including depression, and it’s no longer sold as a medicine in the US. There are no human studies showing rauwolfia serpentina helps with weight loss, so it’s a poor choice as a “fat burner”.
Rauwolfia serpentina (also called Indian snakeroot or sarpagandha) has a long history in traditional medicine, and it’s sometimes promoted for weight loss. But this plant isn’t a gentle herb. It’s the natural source of a real blood pressure medicine, with real side effects. Here’s what the research says about what it does, what it doesn’t do, and why you should be cautious.
What is rauwolfia serpentina?
Rauwolfia serpentina is a flowering shrub in the Rauvolfia genus (the spelling varies), which has about 74 species. Its root is one of the most widely used parts of these plants in traditional medicine, mainly for nervous system problems and heart and blood vessel conditions [1].
Researchers have found around 287 alkaloids (natural nitrogen-containing compounds, many of which act strongly on the body) in plants of this genus. The best known are reserpine, ajmaline, ajmalicine, serpentine and yohimbine [1]. Reserpine is the one that made rauwolfia famous.

Doctors in India used rauwolfia for high blood pressure in the 1940s, and in the 1950s it was used around the world, including in the United States and Canada. It later fell out of favor when it was linked to side effects such as depression and, possibly, cancer [2]. Reserpine has long been used as a prescription blood pressure medicine, but according to the US National Library of Medicine, it’s no longer available in the United States [3].
Rauwolfia serpentina and blood pressure
Reserpine works by slowing the activity of the nervous system, which slows the heartbeat and relaxes blood vessels [3].
The best summary of the evidence is a Cochrane review (an independent review that pools the best-quality trials). It found only four randomized controlled trials (studies where people are assigned to treatments by chance), with 237 people in total, that compared reserpine or a rauwolfia extract with a placebo (a dummy pill) or no treatment in people with high blood pressure [4]. Pooling the three reserpine trials, reserpine lowered systolic blood pressure (the top number) by about 8 mmHg (millimeters of mercury, the unit used for blood pressure) compared with placebo, at doses of 0.5 mg a day or more. The trials varied too much to show a clear effect on diastolic blood pressure (the bottom number) [4].
The reviewers said reserpine lowers systolic pressure about as much as other first-line blood pressure drugs (the ones doctors usually try first), but with so few trials they couldn’t work out the best dose, and there wasn’t enough data to judge side effects. One of the four trials tested a different rauwolfia alkaloid extract rather than pure reserpine, so it was analyzed separately [4].
Some practitioners still argue for low-dose rauwolfia as an add-on treatment for high blood pressure [2]. But that’s a decision for a doctor who can monitor you. A supplement isn’t a safe way to treat blood pressure: you can’t be sure how much reserpine a product contains, and modern blood pressure medicines have much stronger evidence behind them. If you have high blood pressure, talk to your doctor before trying any herb.
Does rauwolfia serpentina cause depression?
An older US prescribing label for a reserpine-containing blood pressure pill warns that reserpine “may cause mental depression”, that the depression can last for months after stopping, and that it may be severe enough to lead to suicide [5]. The label says to stop the drug at the first signs of depression, and not to use it at all in people with a history of depression [5].
The research picture is more mixed than that warning suggests. A systematic review (a study that gathers and grades all the available research), published online in 2022, found 35 studies, 9 of them randomized trials. Eleven reported some depression-causing effects, 13 found no effect, and 11 suggested reserpine might even help depression [6]. Depression was more often reported in people who didn’t have a mental health condition to begin with, while possible benefits came mostly from small, short, high-dose studies in psychiatric patients. Most studies (30 of 35) were at high risk of bias (flaws in design that can skew the results), so the reviewers concluded the link is “inconsistent” and backed by little high-quality evidence [6].
Our older version of this article called reserpine-induced depression a “myth”. That went too far. The honest answer is that we don’t know for sure, and the risk is serious enough that anyone with a history of depression should avoid rauwolfia.
Is rauwolfia serpentina a weight loss supplement?
We couldn’t find any human studies testing rauwolfia serpentina, or reserpine, for weight loss. So why does it appear in “fat burners”? Probably because Rauvolfia plants contain yohimbine-type alkaloids [1], and these have a reputation for fat loss.
One of them, rauwolscine (also called alpha-yohimbine), is a close chemical relative of yohimbine. In lab tests on cow brain tissue, it binds strongly and specifically to alpha-2 adrenergic receptors (sites that normally act as a brake on the release of noradrenaline, a chemical messenger), which it blocks [7]. Supplement marketing suggests this helps the body release stored fat, but that’s a theory. We found no published human trials of rauwolscine for weight loss.
Yohimbine itself has very little research as a supplement in people. The US National Center for Complementary and Integrative Health (NCCIH) says there isn’t enough evidence that it works for weight loss or athletic performance [8]. In one small randomized trial, 20 professional soccer players who were doing resistance training took 20 mg of yohimbine a day or a placebo for 21 days. Body fat percentage fell in the yohimbine group (from 9.3% to 7.1%), but body weight, muscle mass and performance didn’t change [9]. That’s a single, short study in lean young athletes, so it doesn’t tell us much about weight loss for everyone else. You can read more in our yohimbine article.
Yohimbine also comes with risks. It has been linked to irregular heartbeat, blood pressure problems, heart attacks and seizures, and most yohimbe products don’t say how much yohimbine they contain [8]. Products that mix rauwolfia (which lowers blood pressure) with yohimbine-type stimulants make it even harder to predict what you’re taking. Other weight loss supplements have similar problems; see our reviews of bitter orange (synephrine) and green coffee weight loss.
Rauwolfia serpentina and blood sugar
A root extract of rauwolfia serpentina improved blood sugar, insulin and blood fats in mice with fructose-induced type 2 diabetes when given for 14 days at 10 to 60 mg per kg of body weight [10]. That’s an early animal finding. We found no good-quality modern human trials of rauwolfia for blood sugar, so it can’t tell you whether rauwolfia helps human blood sugar.
Rauwolfia serpentina side effects and safety
Because rauwolfia’s main active compound is a prescription drug, its side effects are well documented. According to US drug information and the older reserpine label, they include [3, 5]:
- Common effects: dizziness, drowsiness, dry mouth, headache, a stuffy nose, upset stomach, diarrhea, loss of appetite and lower sex drive or erection problems.
- Serious effects: depression, a slow heartbeat, fainting, nightmares, chest pain and swollen ankles or feet.
The label says reserpine shouldn’t be used by people with a history of depression, or by people with a peptic ulcer (a sore in the lining of the stomach or gut) or ulcerative colitis (an inflammatory bowel disease), partly because reserpine can increase stomach acid [5].
It also warns about drug interactions [5]:
- MAO inhibitors (a type of antidepressant): the combination can cause overstimulation and high blood pressure, so it should be avoided.
- Heart medicines such as digitalis or quinidine: use with caution because of possible heart rhythm problems.
- Surgery: people having anesthesia while on reserpine have had unexpectedly low blood pressure and slow heart rates, so the label advises stopping it one to two weeks before planned surgery.
Cancer concerns. In two-year rodent studies, reserpine caused tumors at roughly 100 to 300 times the usual human dose [5]. In people, a 2001 review pooled case-control studies (which compare people with a disease to similar people without it) of 5,852 women with breast cancer and 9,776 women without it. Rauwolfia drug use was linked to 25% higher odds of breast cancer, which the authors described as a “low grade” association [11]. The reserpine label says the human evidence is “too limited to be conclusive” [5], and some authors dispute the link altogether [2]. So the link hasn’t been proven, but it hasn’t been ruled out either.
Pregnancy and breastfeeding. Reserpine crosses the placenta [5]. It has been reported to cause a stuffy nose and extra mucus in breastfed babies, although this isn’t well documented, and a US government drug database recommends using a different drug while breastfeeding [12]. Rauwolfia supplements aren’t appropriate during pregnancy or breastfeeding.
Avoid rauwolfia serpentina if you have depression or a history of it, a stomach ulcer or ulcerative colitis [5]. Check with your doctor first if you take any antidepressant, heart or blood pressure medicine, or if you already have low blood pressure or a slow heart rate. If you’re already taking a product that contains it, talk to your doctor or pharmacist.
The bottom line on rauwolfia serpentina
Rauwolfia serpentina is the source of reserpine, a real blood pressure drug that lowers systolic pressure by about 8 mmHg in small trials. That also makes it a drug-strength herb, with side effects such as depression, drowsiness, a slow heartbeat and drug interactions.
There’s no human evidence that rauwolfia serpentina helps with weight loss, and its close chemical relative yohimbine, the compound behind many “fat burner” claims, has very little supplement research and real heart risks. If you want to lower your blood pressure or lose weight, a doctor can help you find options with much stronger evidence and fewer risks.
This article is for general information only and isn’t medical advice. Talk to your doctor or another qualified health professional before starting a new supplement. See our medical disclaimer.
References
- Kumar S, Kumari D, Singh B. Genus Rauvolfia: a review of its ethnopharmacology, phytochemistry, quality control/quality assurance, pharmacological activities and clinical evidence. J Ethnopharmacol. 2022;295:115327. doi:10.1016/j.jep.2022.115327
- Lobay D. Rauwolfia in the treatment of hypertension. Integr Med (Encinitas). 2015;14(3):40-46. PubMed 26770146
- MedlinePlus. Reserpine. US National Library of Medicine. Last revised June 20, 2024. medlineplus.gov/druginfo/meds/a601107.html
- Shamon SD, Perez MI. Blood pressure-lowering efficacy of reserpine for primary hypertension. Cochrane Database Syst Rev. 2016;12(12):CD007655. doi:10.1002/14651858.CD007655.pub3
- Renese-R (polythiazide and reserpine) tablets: prescribing information. Pfizer Labs. DailyMed, US National Library of Medicine. dailymed.nlm.nih.gov
- Strawbridge R, Javed RR, Cave J, Jauhar S, Young AH. The effects of reserpine on depression: a systematic review. J Psychopharmacol. 2023;37(3):248-260. doi:10.1177/02698811221115762
- Perry BD, U’Prichard DC. [3H]rauwolscine (alpha-yohimbine): a specific antagonist radioligand for brain alpha 2-adrenergic receptors. Eur J Pharmacol. 1981;76(4):461-464. doi:10.1016/0014-2999(81)90123-0
- National Center for Complementary and Integrative Health. Yohimbe. Updated May 2025. nccih.nih.gov/health/yohimbe
- Ostojic SM. Yohimbine: the effects on body composition and exercise performance in soccer players. Res Sports Med. 2006;14(4):289-299. doi:10.1080/15438620600987106
- Azmi MB, Qureshi SA. Rauwolfia serpentina improves altered glucose and lipid homeostasis in fructose-induced type 2 diabetic mice. Pak J Pharm Sci. 2016;29(5):1619-1624. PubMed 27731821
- Grossman E, Messerli FH, Goldbourt U. Antihypertensive therapy and the risk of malignancies. Eur Heart J. 2001;22(15):1343-1352. doi:10.1053/euhj.2001.2729
- Reserpine. In: Drugs and Lactation Database (LactMed). National Institute of Child Health and Human Development; revised November 15, 2024. ncbi.nlm.nih.gov/books/NBK501093

